Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05430204 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 1,628
- Enrollment target
NCT05430204 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,628 participants.
The verdict
NCT05430204, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,628 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether Continuous glucose monitoring (CGM) for diagnosis of gestational diabetes mellitus (GDM) improves maternal and neonatal outcomes related to GDM and to evaluate whether CGM for GDM diagnosis reduces the health system costs for mother-infant dyads compared to usual care
Interventions
- DEVICE Group 1: one-hour GCT
- DEVICE Group 2: CGM placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,628 participants |
| Start Date | 2023-03-07 |
| Est. Completion | 2024-09-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05430204
The ClinicalTrials.gov registry entry for NCT05430204 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,628 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Group 1: one-hour GCT is the first listed.
NCT05430204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05430204 about?
NCT05430204 is a clinical study titled "Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy". The purpose of this study is to evaluate whether Continuous glucose monitoring (CGM) for diagnosis of gestational diabetes mellitus (GDM) improves maternal and neonatal outcomes related to GDM and to evaluate whether CGM for GDM diagnosis reduces the health system costs for mother-infant dyads compa...
What is the current status of trial NCT05430204?
This trial is currently completed. It is a NA study. The enrollment target is 1,628 participants. The study started on 2023-03-07. Estimated completion is 2024-09-16.
What interventions are being tested in trial NCT05430204?
The interventions under investigation include: Group 1: one-hour GCT (DEVICE), Group 2: CGM placement (DEVICE).
Who is sponsoring clinical trial NCT05430204?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.